SkyePharma obtains exclusive rights over treatment for lymphomatous meningitis
Representing SkyePharma Plc in its grant of exclusive marketing and distribution rights for DepoCyte®, a treatment for lymphomatous meningitis, to Mundipharma International Holdings Limited for most European and Eastern European countries.